(Q22252385)

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Immune activation is a dominant factor in the pathogenesis of African AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Lack of induction of interleukin-2-receptor-alpha in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

HIV-1 disease progression and AIDS-defining disorders in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The acquisition of host-encoded proteins by nascent HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Influence of microbial infections on the progression of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The evaluation of potential global morbidity attributable to intestinal nematode infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The natural history of HIV-1 infection in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Human immunodeficiency virus infection among employees in an African hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Sexual transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Malaria infection induces virus expression in human immunodeficiency virus transgenic mice by CD4 T cell-dependent immune activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Seroconversion rate, mortality, and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Cellular transcription factors involved in the regulation of HIV-1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Immune activation and induction of HIV-1 replication within CD14 macrophages during acute Plasmodium falciparum malaria coinfection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Epidemiological Synergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Increased Replication of HIV-1 at Sites of Mycobacterium tuberculosis Infection: Potential Mechanisms of Viral Activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Treatment of intestinal worms is associated with decreased HIV plasma viral load

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Programmed death of T cells in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Macrophages as a source of HIV during opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Accelerated course of human immunodeficiency virus infection after tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021

Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JINF.2003.09.001

7 January 2021